Entegrion, Inc.赞助的临床试验
总计35578个结果
-
Cascadian Therapeutics Inc.完全的
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)完全的
-
Seagen Inc.Millennium Pharmaceuticals, Inc.完全的
-
Taiho Oncology, Inc.Quintiles, Inc.完全的Secondary Malignant Neoplasm of Pancreas
-
Astex Pharmaceuticals, Inc.Eisai Inc.完全的
-
Estrella Biopharma, Inc.Eureka Therapeutics Inc.尚未招聘淋巴瘤 | 淋巴瘤,非霍奇金 | 非霍奇金淋巴瘤 | 非霍奇金淋巴瘤 | 难治性 B 细胞非霍奇金淋巴瘤 | 难治性非霍奇金淋巴瘤 | 高级别 B 细胞淋巴瘤 | 中枢神经系统淋巴瘤 | 淋巴瘤非霍奇金 B 细胞 | 复发性非霍奇金淋巴瘤 | 淋巴瘤,非霍奇金 | 大 B 细胞淋巴瘤 | 淋巴瘤,非霍奇金,成人 | HIV相关淋巴瘤 | B 细胞非霍奇金淋巴瘤 (NHL)
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.; Ortho Biotech, Inc.终止
-
Sebela Women's Health Inc.Synteract, Inc.主动,不招人
-
Astellas Pharma China, Inc.Seagen Inc.主动,不招人
-
UNC Lineberger Comprehensive Cancer CenterAmerican Cancer Society, Inc.完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma US, Inc.; Medivation, Inc.; Biologics, Inc.主动,不招人
-
gicare Pharma Inc.Algorithme Pharma Inc; JSS Medical Research Inc.完全的
-
Astellas Pharma Global Development, Inc.Medivation, Inc.批准上市
-
Urotronic Inc.Laborie Medical Technologies Inc.招聘中
-
EnhancedBio USA Inc.Zenopharm招聘中
-
General Oncology, Inc.Myriad Genetics, Inc.招聘中胰腺癌 | 胰腺导管腺癌 | 胰腺癌 IV 期 | 乳腺癌第四期 | BRCA1突变 | BRCA2突变 | 胰腺腺泡细胞癌 | 转移性胰腺癌 | 乳腺癌转移 | HER2 阴性乳腺癌 | 转移性胰腺导管腺癌 | HER2 阴性乳腺癌 | 胰腺癌转移 | 乳腺癌 | PALB2基因突变美国
-
Arvinas Androgen Receptor, Inc.主动,不招人
-
IVERIC bio, Inc.完全的